436
Participants
Start Date
January 31, 2013
Primary Completion Date
May 14, 2015
Study Completion Date
May 14, 2015
Romozosumab
Administered by subcutaneous injection once a month.
Teriparatide
Administered by subcutaneous injection once a day.
Research Site, Budapest
Research Site, Budapest
Research Site, Budapest
Research Site, Hvidovre
Research Site, Ballerup Municipality
Research Site, Leuven
Research Site, Hillerød
Research Site, Genk
Research Site, Liège
Research Site, Odense
Research Site, Esbjerg
Research Site, Aarhus C
Research Site, Ghent
Research Site, Aalborg
Research Site, Granada
Research Site, Bethesda
Research Site, Madrid
Research Site, Madrid
Research Site, Pozuelo de Alarcón
Research Site, Gainesville
Research Site, Detroit
Research Site, Boston
Research Site, Boston
Research Site, Ciudad Autonoma de Buenos Aires
Research Site, Ciudad Autonoma de Buenos Aires
Research Site, Córdoba
Research Site, Calgary
Research Site, Vancouver
Research Site, Toronto
Research Site, Toronto
Research Site, Québec
Research Site, Medellín
Research Site, Barranquilla
Research Site, Brno
Research Site, Ostrava
Research Site, Pilsen
Research Site, Praha 11 - Chodov
Research Site, Uherské Hradiště
Research Site, Gdynia
Research Site, Katowice
Research Site, Warsaw
Research Site, Wroclaw
Research Site, Barcelona
Research Site, LHospitalet de Llobregat
Research Site, Cardiff
Research Site, Chorley
Research Site, Liverpool
Research Site, Northwood
Research Site, Reading
Research Site, Sidcup
Lead Sponsor
Amgen
INDUSTRY